Kazia Therapeutics Ltd
Pharmaceutical company · Sydney Nsw, New South Wales, Australia · Nasdaq: KZIA
Kazia Therapeutics Ltd is a pharmaceutical company headquartered in Sydney Nsw, New South Wales, Australia. Its shares trade on Nasdaq under the ticker KZIA. It has reported private securities offerings to the US SEC, most recently $55 million sold in a notice filed in 2025.
Kazia Therapeutics at a glance
What does Kazia Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $55.3 million sold (2025).
Frequently asked questions about Kazia Therapeutics
Where is Kazia Therapeutics headquartered?
Kazia Therapeutics Ltd is headquartered in Sydney Nsw, New South Wales, Australia.
What does Kazia Therapeutics do?
Kazia Therapeutics Ltd is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Kazia Therapeutics a public company?
Yes. Kazia Therapeutics Ltd trades on Nasdaq under the ticker KZIA.
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.